Laurion Capital Management »

Immunic shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 1.9M 0.88
2025-06-30 $1.3M 1.9M 0.70
2025-03-31 $249k 228k 1.09

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Immunic

Standard Life Aberdeen
BVF
Avidity Partners Management
Vanguard Group
Morgan Stanley
Colony
Laurion Capital Management
Soleus Capital Management
Adage Capital Partners GP
Geode Capital Management
Ikarian Capital
BlackRock
Citadel Advisors
Marshall Wace
Millennium Management

View all funds holding Immunic